We assessed whether differences in renal function and HTN status, two clinical risk factors for ccRCC that are more prevalent among B individuals, could account for the differences observed in VHL frequency between the AFR and EUR cohorts (25). The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.